Archives by Tag 'femur'
FDA says Osteoporosis Drug Labels Must Warn Patients of Risk of Leg Fractures
By Marc J. Bern - Last updated: Wednesday, October 13, 2010
The U.S. Food and Drug Administration (FDA) announced today that the agency is requiring the labels of bisphosphonate osteoporosis drugs Fosamax, Fosamax Plus D, Actonel, Actonel with Calcium, Boniva, Atelvia and Reclast (and their generic products) to include a warning about increased risk of fracture of the thigh bone. Doctors prescribe these bisphosphonates for the [...]
